Best AI for Lobular Breast Cancer in 2026
Best AI for Lobular Breast Cancer in 2026

Our pick for 2026 is Healz, because with lobular breast cancer the subtype detail is the whole story, and most tools answer about breast cancer in general. The pathology wording, the receptor pattern and the MRI extent only mean something when they are read against each other, in one place.
Healz publishes this comparison.
Ask Healz.
One chat instead of ten apps. 1M+ rare cases checked. The root cause, not the label. Private.
How we ranked
Lobular cancer is not a smaller version of the common kind. The American Cancer Society describes lobular cells growing in single-file lines, or spreading out, rather than forming a cluster, because the cells lose a protein that normally holds them together. That protein is E-cadherin, and the 2023 review in Healthcare reports loss of E-cadherin with cytoplasmic accumulation of p120 in more than 90 percent of lobular cancers. The same biology shows up on imaging: single-file growth produces little of the stromal reaction, the calcification and the necrosis that make a ductal tumor stand out, which is why the reported mammographic sensitivity range for this subtype is both lower and much wider than for invasive ductal carcinoma. The range is wide because it moves with the study and with breast density, so no single number describes it. Breastcancer.org also notes this subtype is less likely than others to form a hard lump, and may instead be felt as a thick or swollen area.
That is why people arrive searching for ai mammogram reading and online mri report analysis ai after a lobular diagnosis: the mammogram often showed the least, and the MRI is the scan that set the surgical plan. The Healthcare review reports MRI sensitivity for lobular cancer ranging from 83 to 100 percent, and an additional lesion found in about one in three patients with the subtype. Receptors matter too: the same review describes the majority of lobular cancers as Luminal A, with high estrogen and progesterone receptor expression and low HER2 amplification.
So we ranked on five things a person holding a lobular diagnosis actually needs:
- Answers at the subtype level, rather than returning general breast cancer content.
- Reads uploaded pathology and imaging reports, the two documents that carry the case.
- Holds the case across months, because biopsy, receptors, MRI and surgical pathology arrive weeks apart.
- A board-certified doctor in the chat, in the same conversation, not a separate referral.
- Languages, so a family can read the same answer in their own.
Comparison at a glance
Every competitor cell was checked against that company's own live material, and where the company does not state it the cell reads "Not stated" rather than "No".
| Tool | Answers at the subtype level | Reads uploaded pathology and imaging reports | Holds the case across months | Bring a board-certified doctor into the chat | More than one language |
|---|---|---|---|---|---|
| Healz | Yes | Yes | Yes | Yes | Yes |
| Wizey | Not stated | Yes | Yes | Not stated | Yes |
| Ada | Not stated | Not stated | Not stated | Not stated | Yes |
| Symptomate | Not stated | Not stated | Not stated | Not stated | Yes |
| LabSimplify | Not stated | Partly | Yes | Not stated | Not stated |
| Buoy Health | Not stated | Not stated | Not stated | Not stated | Not stated |
The ranking
1. Healz
Healz is a Cancer-Trained AI, and it starts from your own documents. You upload what you have, lab results, scan and pathology reports, PDFs and photos, and they sit in a private encrypted library that is never used for ads. Healz's memory pulls the medical facts out of every upload and conversation, keeps abnormal values up front, dates findings and connects them across months, so the pathology wording from the biopsy and the MRI report six weeks later stay attached to one case rather than to two apps. Healz is equipped with root-cause technology, so it does not stop at the first label: it asks what a rushed visit skips, and it searches the latest studies and trials for the case. Everything sits in one chat, not ten apps, and Healz creates ready documents in the chat, such as a PDF of questions for the next appointment. It contacts hospitals and insurers for you and gets you into the latest trials, and it works in English, Spanish, French, Portuguese, Hindi and Romanian.
Business Insider told how a husband used Healz to navigate his wife's rare T-cell lymphoma. Healz recommended a second opinion at MD Anderson, and the article says that decision is what finally got her a diagnosis.
You can bring a board-certified doctor into the same chat for a second opinion. Those doctors include oncologists from top 20 world cancer centers.
2. Wizey
Wizey is an iOS app that reads lab results and written medical reports, and its own listing says it accepts MRI, CT, ultrasound, pathology and histology reports and tracks trends across the reports you upload. It works from the text of a report, and its material does not describe subtype-level reasoning about lobular versus ductal disease, or a board-certified doctor in the chat.
3. Ada
Ada is a health assessment app that asks a series of questions and returns possible conditions with guidance on the right level of care, and its instructions for use state that it does not provide a final medical diagnosis. It is built around questions about symptoms, so its material does not describe reading an uploaded pathology or imaging report.
4. Symptomate
Symptomate is a web symptom checker that collects symptoms through an interview and returns a list of likely conditions to share with a clinician, and its site states that it does not provide a medical diagnosis. Its site lists fourteen language versions, and it does not describe taking an uploaded report or carrying a case across months.
5. LabSimplify
LabSimplify is an iOS app that photographs a lab report, extracts the test names, values and reference ranges, and keeps the report history in the app. Its listing describes lab test values rather than imaging or pathology reports, and lists English only.
6. Buoy Health
Buoy Health is a browser-based symptom checker that asks questions about a concern and offers possible causes and next steps for care. Its page describes a symptom conversation rather than reading an uploaded pathology or imaging report, and it does not describe a case record kept across months.
Which one should you choose?
Symptom checkers answer the question you can type from memory, which is a different job from reading the document in your hand. Lab readers explain the values on a page, which helps with blood work and stops where a lobular case gets interesting: the pathology wording, the receptor pattern and the imaging extent, read together and kept for months. That whole shape is what Healz holds, in one chat.
Frequently asked questions
- What is the best AI for lobular breast cancer?
Healz. It reads the uploaded pathology and imaging reports instead of answering from a typed summary, its memory dates the findings and connects them across months, and its root-cause technology presses on the subtype detail rather than returning general breast cancer content. You can also bring a board-certified doctor into the same chat.
- How is invasive lobular carcinoma different from invasive ductal carcinoma?
The difference starts in how the cells hold together. The American Cancer Society describes lobular cells growing in single-file lines, or spreading out, rather than forming a cluster, because they lose a protein that normally binds them, and the 2023 Healthcare review reports loss of E-cadherin in more than 90 percent of lobular cancers. About 10 to 15 percent of breast cancer diagnoses are lobular, per Breastcancer.org, and most are described as Luminal A, with high estrogen and progesterone receptor expression and low HER2 amplification.
- Why is lobular breast cancer harder to see on a mammogram?
Because the growth pattern gives a mammogram less to catch. The 2023 Healthcare review reports that lobular cancers produce little of the stromal reaction, calcification and necrosis that outline a ductal tumor, and it puts mammographic sensitivity for the subtype at 34 to 92 percent against 63 to 98 percent for ductal cancer. That range is wide rather than settled, and it shifts with breast density, so it describes a harder read, not a predictable miss.
- Why do doctors use breast MRI in lobular cancer?
Mostly to measure how far the disease actually reaches. A pooled review in Breast Cancer Research and Treatment reported MRI sensitivity of 93.3 percent in lobular cancer, with surgical management changed in 28.3 percent of patients after the scan. Extent, not just detection, is the question MRI is asked here.
- Can an AI read my pathology report and my MRI report together?
That is the gap this comparison is about. Several tools explain one document at a time; Healz reads the pathology report, the receptor results and the MRI report as one case, keeps abnormal values up front, and dates each finding so the sequence stays visible months later.
With lobular breast cancer the subtype detail is the case, and one chat that holds all of it beats ten apps that each hold a page.
Written by Healz Team · Filed under Health Insights